Literature DB >> 27067787

Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases.

Li Liang1, He Huang1, Vipulkumar Dadhania1, Jing Zhang2, Miao Zhang3, Jinsong Liu4.   

Abstract

Renal cell carcinoma (RCC), the most common type of kidney cancer in adult, rarely metastasizes to the ovary or fallopian tube, and most cases published in the literature were case reports. Herein, we describe the clinicopathological features of 9 cases of RCC metastatic to the ovary (n = 8) or the fallopian tube (n = 1). The patients' age at the onset of primary renal tumor was available in 8 patients, ranging from 37 to 73 years (mean, 51 years; median, 50 years). Ovarian metastasis was detected prior to or concurrently with the primary renal tumors in 3 patients, and after the diagnosis of renal tumors in 6 patients. The histotypes of the RCCs were clear cell (n = 7), chromophobe (n = 1), and unclassified (n = 1). Immunohistochemical stainings were performed on the sections containing metastatic tumors in 4 cases. Interestingly, pagetoid intraepithelial spread in the tubal mucosa was observed in the case of RCC metastatic to the fallopian tube. Among the 8 patients with follow-up data, 5 died of disease and 3 were alive with disease, with a follow-up period ranging from 3.7 months to 17 years (mean, 77 months; median, 53 months) after the diagnosis of primary kidney tumors. Diagnostically, metastatic RCC may mimic primary ovarian tumors clinically, morphologically, or immunophenotypically. Pathologists should also keep in mind that both ovarian and kidney tumors express PAX8 and PAX2, the markers commonly used to diagnose metastatic RCC. In addition, chromophobe RCC only rarely metastasizes, but it can be a diagnostic challenge when it metastasizes to the ovary.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fallopian tube; Metastasis; Pagetoid spread; Renal cell carcinoma; Secondary ovarian tumor

Mesh:

Year:  2016        PMID: 27067787      PMCID: PMC4830916          DOI: 10.1016/j.humpath.2015.12.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  28 in total

1.  Renal cell carcinoma metastatic to the ovary.

Authors:  Esther Udoji; Brian R Herts
Journal:  J Urol       Date:  2012-06-15       Impact factor: 7.450

Review 2.  Ovarian metastasis of a primary renal cell carcinoma: case report and review of literature.

Authors:  S Guney; N Guney; D Ozcan; T Sayilgan; E Ozakin
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

3.  Diagnostic value of cytokeratin 7, CD10 and mesothelin in distinguishing ovarian clear cell carcinoma from metastasis of renal clear cell carcinoma.

Authors:  X Leroy; M-O Farine; D Buob; A Wacrenier; M-C Copin
Journal:  Histopathology       Date:  2007-12       Impact factor: 5.087

4.  A case of renal cell carcinoma with solitary metastasis to the ovary.

Authors:  M Dolanbay; M S Kutuk; S Uludag; M T Ozgun; F Ozturk; B Ozcelik
Journal:  J Obstet Gynaecol       Date:  2014-08-20       Impact factor: 1.246

5.  Ovarian metastasis of clear cell renal cell carcinoma: A case report.

Authors:  Lenka Bauerová; Pavel Dundr; Daniela Fischerová; Michael Pešl; Michal Zikán; Andrea Burgetová
Journal:  Can Urol Assoc J       Date:  2014 Mar-Apr       Impact factor: 1.862

Review 6.  Metastatic ovarian tumors: a review of 64 cases.

Authors:  Namiko Yada-Hashimoto; Toshiya Yamamoto; Shoji Kamiura; Hozumi Seino; Hiroki Ohira; Keisuke Sawai; Tadashi Kimura; Fumitaka Saji
Journal:  Gynecol Oncol       Date:  2003-05       Impact factor: 5.482

Review 7.  Secondary ovarian malignancies: frequency, origin, and characteristics.

Authors:  Yvonne R P de Waal; Chris M G Thomas; Angèle L M Oei; Fred C G J Sweep; Leon F A G Massuger
Journal:  Int J Gynecol Cancer       Date:  2009-10       Impact factor: 3.437

8.  A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.

Authors:  R I Cameron; P Ashe; D M O'Rourke; H Foster; W G McCluggage
Journal:  Int J Gynecol Pathol       Date:  2003-07       Impact factor: 2.762

9.  Metastasis from papillary renal cell carcinoma masquerading as primary ovarian clear cell tumor.

Authors:  Simona Stolnicu; Angela Borda; Doinita Radulescu; Lucian Puscasiu; Nicole Berger; Francisco F Nogales
Journal:  Pathol Res Pract       Date:  2007-10-01       Impact factor: 3.250

10.  Metastatic renal cell carcinoma to the ovary: a case report and discussion of differential diagnoses.

Authors:  Lauren Hammock; Zeina Ghorab; Carmen R Gomez-Fernandez
Journal:  Arch Pathol Lab Med       Date:  2003-03       Impact factor: 5.534

View more
  5 in total

1.  Imaging findings of ovarian metastasis of primary renal cell carcinoma: A case report and literature review.

Authors:  Ayumi Takayanagi; Fumi Kato; Ayako Nozaki; Ryuji Matsumoto; Takahiro Osawa; Ken Kuwahara; Yoshihiro Matsuno; Hiroshi Asano; Tatsuya Kato; Hidemichi Watari; Takashige Abe; Nobuo Shinohara; Kohsuke Kudo
Journal:  Radiol Case Rep       Date:  2022-05-05

2.  Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female.

Authors:  Manoj Pandey; Mahendran Ramasamy; Mridula Shukla
Journal:  World J Surg Oncol       Date:  2018-02-06       Impact factor: 2.754

Review 3.  Kidney Carcinoma Ovarian Metastasis: Review of the Literature.

Authors:  Nektarios Koufopoulos; Despoina Nasi; Foteini Antoniadou; Stefania Kokkali; Stamatios Theocharis
Journal:  Cureus       Date:  2018-11-21

4.  LeMeDISCO is a computational method for large-scale prediction & molecular interpretation of disease comorbidity.

Authors:  Courtney Astore; Hongyi Zhou; Bartosz Ilkowski; Jessica Forness; Jeffrey Skolnick
Journal:  Commun Biol       Date:  2022-08-25

5.  Renal Cell Carcinoma with Direct Extension into the Gonadal Vein, Uterus, Fallopian Tube, and Bilateral Ovaries: A Case Report.

Authors:  Sarah E Sweigert; Petar Bajic; Alessa Aragao; Maria Picken; Michael E Woods
Journal:  J Kidney Cancer VHL       Date:  2020-08-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.